Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Trends of antimicrobial susceptibilities and multidrug-resistant colonization rate in patients transferred from long-term care facilities during 2017–2022: a cross-sectional study

Fig. 1

Antimicrobial susceptibility and ESBL-producing rate according to years in Enterobacterales isolates. a Overall antimicrobial susceptibilities and (b) trend of antimicrobial susceptibilities in Enterobacterales isolates from 2017 to 2022. Susceptibilities to ampicillin/sulbactam, ceftazidime, cefepime, and ertapenem significantly decreased according to years (P = 0.046, P < 0001, P < 0.001, and P = 0.013, respectively). Abbreviations: CIP, ciprofloxacin; CTX, cefotaxime; SAM, ampicillin/sulbactam; TMP/SMX, trimethoprim/sulfamethoxazole; GEN, gentamicin; CAZ, ceftazidime; FEP, cefepime; TZP, piperacillin/tazobactam; AMK, amikacin; ETP, ertapenem; IPM, imipenem; ESBL, extended spectrum b-lactamase

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us